Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05704829
Title NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer (ADAPTHER2-IV)
Acronym ADAPTHER2-IV
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors West German Study Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Munich Bavaria 81377 Germany Details
Rotkreuz Klinikum München Muenchen Bayern 80637 Germany Details
Niels-Stensen-Kliniken Franziskus-Hospital Georgsmarienhütte Niedersachsen 49124 Germany Details
Kliniken Essen-Mitte, Klinik für Senologie/Interdisziplinäres Brustzentrum Essen NRW 45136 Germany Details
Brustzentrum Niederrhein, Johanniter Bethesda Krankenhaus Moenchengladbach NRW 41061 Germany Details
Klinikum Mittelbaden, Brustzentrum Baden-Baden Germany Details
Onkologische Schwerpunktpraxis Bielefeld Bielefeld 33604 Germany Details
Universitätsklinikum Essen, Burstzentrum Essen Germany Details
Onkodok Gütersloh Gütersloh Germany Details
Brustzentrum am Krankenhaus Jerusalem Hamburg Germany Details
St. Barbara Klinik Hamm Germany Details
Helios-Klinik Wuppertal Wuppertal Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field